Publikationen

Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Saletti, G., & Rimmelzwaan, G. F. (2022). Aging and antiviral immune response: anti PD-1 treatment improves T cell function in older adults. In Junior Scientist Zoonoses Meeting 2022: program and abstracts.
Details anzeigen

Becker, T., Elbahesh, H., Reperant, L. A., Rimmelzwaan, G. F., & Osterhaus, A. D. M. E. (2021). Influenza vaccines: successes and continuing challenges. The Journal of Infectious Diseases, 224(Supplement 4), 405-S419. https://doi.org/10.1093/infdis/jiab269
Details anzeigen

Beicht, J., Kubinski, M., Gerlach, T., & Rimmelzwaan, G. F. (2021). Influenza virus-based vector vaccines agasinst tick-borne encephalitis virus (TBEV). In Stiftung Tierärztliche Hochschule Hannover (Ed.), 14th Graduate School Days: 19/20 November 2021 : University of Veterinary Medicine, Institute for Pathology. Abstract book. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Dai, M., Du, W., Martínez-Romero, C., Leenders, T., Wennekes, T., Rimmelzwaan, G. F., van Kuppeveld, F. J. M., Fouchier, R. A. M., Garcia-Sastre, A., de Vries, E., & de Haan, C. A. M. (2021). Analysis of the evolution of pandemic influenza A(H1N1) virus neuraminidase reveals entanglement of different phenotypic characteristics. MBio, 12(3). https://doi.org/10.1128/mbio.00287-21
Details anzeigen

Jo, W. K., Schadenhofer, A., Habierski, A., Kaiser, F. K., Saletti, G., Ganzenmueller, T., Hage, E., Haid, S., Pietschmann, T., Hansen, G., Schulz, T. F., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Ludlow, M. (2021). Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants. Proceedings of the National Academy of Sciences of the United States of America, 118(14). https://doi.org/10.1073/pnas.2026558118
Details anzeigen

Kubinski, M., Beicht, J., Gerlach, T., Volz, A., Sutter, G., & Rimmelzwaan, G. F. (2021). Tick-borne encephalistis virus: development of a vaccine approach based on modified vaccinia virus Ankara. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 14th Graduate School Days: 19/20 November 2021 : University of Veterinary Medicine, Institute for Pathology. Abstract book. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Oosting, S. F., van der Veldt, A. A. M., GeurtsvanKessel, C. H., Fehrmann, R. S. N., van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T. ., Bhattacharya, A., van der Heiden, M., Rimmelzwaan, G. F., Kvistborg, P., Blank, C. U., Koopmans, M. P. G., Huckriede, A. L. W., van Els, C. A. C. M., … de Vries, E. G. E. (2021). mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial. The Lancet oncology, 22(12), 1681–1691. https://doi.org/10.1016/s1470-2045(21)00574-x
Details anzeigen

Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021). Aging and options to halt declining immunity to virus infections. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.681449
Details anzeigen

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines: Open Access Journal, 9(3: 196). https://doi.org/10.3390/vaccines9030196
Details anzeigen

Ricke-Hoch, M., Stelling, E., Lasswitz, L., Gunesch, A. P., Kasten, M., Zapatero-Belinchón, F. J., Brogden, G., Gerold, G., Pietschmann, T., Montiel, V., Balligand, J.-L., Facciotti, F., Hirsch, E., Gausepohl, T., Elbahesh, H., Rimmelzwaan, G. F., Höfer, A., Kühnel, M. P., Jonigk, D., … Hilfiker-Kleiner, D. (2021). Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS ONE, 16(8). https://doi.org/10.1371/journal.pone.0255335
Details anzeigen

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen

Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen

Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen

Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen